Viewing Study NCT00242567


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-25 @ 12:23 AM
Study NCT ID: NCT00242567
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-10-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None zoledronic acid View
None bone metastases View
None prostate cancer View
None hormone-sensitive View